Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > TH-1902 pause is no reason to blame management

<< Previous

Bullboard Posts

Next >>

Comment by Momo25on Dec 08, 2022 3:32pm

168 Views

Post# 35160061

RE:RE:RE:RE:RE:RE:RE:RE:TH-1902 pause is no reason to blame management

Stop saying untrue statements. We are not vomiting on a CEO because the trial didn't work. We are vomiting on a CEO because for at least 2 years he said everything is in line with the plan, we are seeing efficacy in some cancers . A lie after lie . If you and Speceo and others are in love with Levesque, we are not. We invested our money because we were confident that what they are saying is true. Now we know this is not. I guess we gained the right to vomiting on him and on everyone who tries to preserve the credibility of this guy and the board in general. This is the last thing we can do and the least one

<< Previous

Bullboard Posts

Next >>

Three micro-cap value stocks trading at peak pessimism